Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Glendale, California 91206


Purpose:

This is a multiple dose study of NSA-789, the purpose of which is to assess the safety and tolerability in healthy subjects and subjects with Alzheimer's Disease


Criteria:

Inclusion Criteria - Men or women aged 18 - 50 years (healthy subjects) or greater than 55 years old (subjects with Alzheimer's Disease) - Women must be surgically sterile or postmenopausal - Subjects with Alzheimer's Disease must be generally healthy, but may have a stable, chronic illness if well controlled. Exclusion Criteria - Healthy subjects may not be on any prescription or investigation drugs within 30 days of start of study. - Subjects with Alzheimer's Disease may not be on any cholinesterase inhibitors such as donepezil (Aricept®) or rivastigmine (Exelon®) within 4 weeks of the start of the study.


NCT ID:

NCT00795730


Primary Contact:

Study Director
Medical Monitor
Wyeth


Backup Contact:

N/A


Location Contact:

Glendale, California 91206
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.